In a strategic development set to reshape cross-border healthcare trade between South Asia and Eurasia, the Ministry of Health of the Republic of Uzbekistan has aligned with Nutrify Today and Pharma Eurasia to formalise a structured Indo–CIS pharmaceutical and nutraceutical corridor—positioning Uzbekistan as the region’s premier gateway to the Commonwealth of Independent States (CIS) and the wider Eurasian market.
The trilateral initiative integrates policy facilitation, global industry leadership, and a dedicated commercial exhibition platform—creating a scalable and compliance-driven trade architecture for Indian and global manufacturers seeking structured access into high-growth Eurasian markets.
Uzbekistan has rapidly transformed into a regional pharmaceutical and nutraceutical hub through targeted industrial policy, including:
The commercial activation of this corridor will take place at Pharma Eurasia 2026, scheduled for 20–22 May 2026 in Tashkent, Uzbekistan.
Nutrify Today will deploy AI-driven regulatory intelligence and compliance infrastructure to support transparent and scalable cross-border nutraceutical trade.
For Indian pharmaceutical and nutraceutical exporters, this corridor represents one of the most structured and policy-backed market-entry opportunities available today.
